Abstract:It is important to expedite our understanding of antibiotic resistance to address the increasing numbers of fatalities and environmental pollution due to the emergence of antibiotic resistance and multidrug-resistant strains. Here, we combined the CRISPR-enabled trackable genome engineering (CREATE) technology and transcriptomic analysis to investigate antibiotic tolerance in Escherichia coli We developed rationally designed site saturation mutagenesis libraries targeting 23 global regulators to identify fitness-conferring mutations in response to diverse antibiotic stresses. We identified seven novel mutations that confer resistance to the ribosome-targeting antibiotics doxycycline, thiamphenicol, and gentamicin in E. coli To the best of our knowledge, these mutations that we identified have not been reported previously during treatment with the indicated antibiotics. Transcriptome sequencing-based transcriptome analysis was further employed to evaluate the genome-wide changes in gene expression in E. coli for SoxR G121P and cAMP receptor protein (CRP) V140W reconstructions, and improved fitness in response to doxycycline and gentamicin was seen. In the case of doxycycline, we speculated that SoxR G121P significantly increased the expression of genes involved in carbohydrate metabolism and energy metabolism to promote cell growth for improved adaptation. In the CRP V140W mutant with improved gentamicin tolerance, the expression of several amino acid biosynthesis genes and fatty acid degradation genes was significantly changed, and these changes probably altered the cellular energy state to improve adaptation. These findings have important significance for understanding such nonspecific mechanisms of antibiotic resistance and developing new antibacterial drugs.IMPORTANCE The growing threat of antimicrobial resistance poses a serious threat to public health care and motivates efforts to understand the means by which resistance acquisition occurs and how this can be combatted. To address these challenges, we expedited the identification of novel mutations that enable complex phenotypic changes that result in improved tolerance to antibiotics by integrating CREATE and transcriptomic analysis of global regulators. The results give us a better understanding of the mechanisms of resistance to tetracycline antibiotics and aminoglycoside antibiotics and also indicate that the method may be used for quickly identifying resistance-related mutations.

Genetic manipulation of the human gut bacterium Eggerthella lenta reveals a widespread family of transcriptional regulators

Transcriptional Modulation of the Global Regulator CodY Using a Conditional CRISPRi System in Bacillus Licheniformis

Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota

Systems biology elucidates the distinctive metabolic niche filled by the human gut microbe Eggerthella lenta

Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome

Systems biology elucidates the distinctive metabolic niche filled by the human gut microbe <i>Eggerthella lenta</i>

A Toolbox for Genetic Manipulation in Intestinal Clostridium Symbiosum

Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus

CRISPR/Cas-Based Genome Editing for Human Gut Commensal Bacteroides Species

Genome engineering of the human gut microbiome

Genomic and epigenetic landscapes drive CRISPR-based genome editing in Bifidobacterium

Large-scale chemical-genetics of the human gut bacterium Bacteroides thetaiotaomicron

Gut Microbiota Has a Widespread and Modifiable Effect on Host Gene Regulation

Targeted Approaches for In Situ Gut Microbiome Manipulation

Attenuator LRR – a regulatory tool for modulating gene expression in Gram‐positive bacteria

Systems biology illuminates alternative metabolic niches in the human gut microbiome

Decoding the microbiome: advances in genetic manipulation for gut bacteria

Regulation of Enteroendocrine Cell Networks by the Major Human Gut Symbiont Bacteroides thetaiotaomicron

Integrating CRISPR-Enabled Trackable Genome Engineering and Transcriptomic Analysis of Global Regulators for Antibiotic Resistance Selection and Identification in Escherichia coli

In situ targeted base editing of bacteria in the mouse gut

Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environments